Adenosine receptor mRNA expression in normal and failing minipig hearts

Journal of Cardiovascular Pharmacology

Volumn 58, Issue 2, 2011, Pages 149-156

  Del Ry, Silvia ^a   Cabiati, Manuela ^b   Martino, Alessandro ^c   Simioniuc, Anca ^b   Morales, Maria Aurora ^a   Picano, Eugenio ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

ADA; adenosine receptors; chronic heart failure; TNF

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE RECEPTOR; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE; MALE; MESSENGER RNA SYNTHESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE CULTURE;

ANIMALS; CHRONIC DISEASE; COLLAGEN; HEART; HEART FAILURE; HEMODYNAMICS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; SWINE; SWINE, MINIATURE;

EID: 80051786738     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31821dcc0b     Document Type: Article

References (44)

1. Matsumori A, Yamada T, Suzuki H, et al. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994;72: 561-566.
2. Xu Z, Park SS, Mueller RA, et al. Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes. Cardiovasc Res. 2005;65:803-812.
3. Newby AC. Adenosine and the concept of retaliatory metabolites. Trend Biochem Sci. 1984;9:42-44.
4. Picano E. Dipyridamole in myocardial ischemia: Good samaritan or terminator? Int J Cardiol. 2002;83:215-216.
5. Headrick JP, Hack B, Ashton KJ. Acute adenosinergic cardiprotection in the ischemic reperfused heart. Am J Physiol Heart Circ Physiol. 2003; 285:H1797-H1819.
6. Sommerschild HT, Kirkeboen KA. Adenosine and cardioprotection during ischemia and reperfusion-an overview. Acta Anaesthesiol Scand. 2000;44:1038-1055.
7. Fredholm BB, IJzerman AP, Jacobson KA, et al. International Union of Pharmacology, XXV: Nomenclature and classification of adenosine receptors. Pharmacol Rev. 2001;53:527-552.
8. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 2002;50:413-492.
9. Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol. 2002;22:364-373.
10. Peart JN, Headrick JP. Adenosinergic cardioprotection: Multiple receptors, multiple pathways. Pharm Ther. 2007;114:208-221.
11. Varani K, Laghi-Pasini F, Cimurri A, et al. Changes of peripheral A2 adenosine receptors in chronic heart failure and cardiac transplantation. FASEB J. 2003;17:280-282.
12. Franceschi F, Deharo JC, Giorgi R, et al. Peripheral plasma adenosine release in patients with chronic heart failure. Heart. 2009;95:651-655.
13. Cross H, Murphy E, Black RG, et al. Overexpression of A3 receptors decreases heart rate, preserves energetics, and protects ischemic hearts. Am J Physiol Heart Circ Physiol. 2009;283:H1562-H1568.
14. Bader M. Rat models of cardiovascular diseases. Methods Mol Biol. 2010; 597:403-414.
15. Breckenridge R. Heart failure and mouse models. Dis Model Mech. 2010; 3:138-143.
16. Dixon JA, Spinale FG. Large animal models of heart failure: A critical link in the translation of basic science to clinical practice. Circ Heart Fail. 2009;2:262-271.
17. Recchia FA, Lionetti V. Animal models of dilated cardiomyopathy for translational research. Vet Res Commun. 2007;31(suppl 1):35-41.
18. Helmer GA, McKirnan MD, Shabetai R, et al. Regional deficits of myocardial blood flow and function in left ventricular pacing-induced heart failure. Circulation. 1996;94:2260-2267.
19. Lionetti V, Guiducci L, Simioniuc A, et al. Mismatch between uniform increase in cardiac glucose uptake and regional contractile dysfunction in pacing-induced heart failure. Am J Physiol Heart Circ Physiol. 2007;293:H2747-H2756.
20. Lionetti V, Aquaro GD, Simioniuc A, et al. Severe mechanical dyssynchrony causes regional hibernation-like changes in pigs with nonischemic heart failure. J Card Fail. 2009;15:920-928.
21. Prinzen FW, Hunter WC, Wyman BT, et al. Mapping of regional myocardial strain and work during ventricular pacing: Experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol. 1999;33: 1735-1742.
22. Prescimone T, Lionetti V, Caselli C, et al. Severity of regional myocardial dysfunction is not affected by cardiomyocyte apoptosis in non-ischemic heart failure. Pharmacol Res. 2011;63:207-215.
23. Del Ry S, Cabiati M, Lionetti V, et al. Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa. Peptides. 2007; 28:1390-1396.
24. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54-59.
25. Bellina RC, Parodi O, Camici P, et al. Simultaneous in vitro and in vivo validation of nitrogen-13 ammonia for the assessment of regional myocardial blood flow. J Nucl Med. 1990;31:1335-1343.
26. Del Ry S, Cabiati M, Lionetti V, et al. Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. Peptides. 2008;29:2008-2015.
27. Del Ry S, Cabiati M, Lionetti V, et al. Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure. Peptides. 2009;30:1710-1713.
28. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034.
29. Asakura M, Asanuma H, Kim J, et al. Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure. Hypertens Res. 2007;30:781-787.
30. Funakoshi H, Zacharia LC, Zhonghua T, et al. A1 adenosine receptor upregulation accompanies decreasing myocardial adenosine levels in mice with left ventricular dysfunction. Circulation. 2007;115:2307-2315.
31. Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611-622.
32. Kitakaze M, Hori M, Kamada T. Role of adenosine and its interaction with alpha adrenoceptor activity in ischaemic and reperfusion injury of the myocardium. Cardiovasc Res. 2002;27:18-27.
33. Bertolet BD, Anand IS, Bryg RJ, et al. Effects of A1 adenosine receptor agonism using N6-cyclohexyl-2#-O-methyladenosin in patients with left ventricular dysfunction. Circulation. 1996;941:212-215.
34. Liao Y, Takashima S, Asano Y, et al. Activation of adenosine A 1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model. Circ Res. 2003;93:759-766.
35. Givertz MM, Massie BM, Fields TK, et al; CKI-201 and CKI-202 Investigators. The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol. 2007;50:1551-1560.
36. Talukder MA, Morrison RR, Ledent C, et al. Endogenous adenosine increases coronary flow by activation of both A2A and A2B receptors in mice. J Cardiovasc Pharmacol. 2003;41:562-570.
37. Monahan TS, Sawmiller DR, Fenton RA, et al. Adenosine A(2a)-receptor activation increases contractility in isolated perfused hearts. Am J Physiol Heart Circ Physiol. 2000;279:H1472-H1481.
38. Capecchi PL, Camurri A, Pompella G, et al. Upregulation of A2A adenosine receptor expression by TNF-a in PBMC of patients with CHF: A regulatory mechanism of inflammation. J Card Fail. 2005;11:67-73.
39. Sun CX, Zhong H, Mohsenin A, et al. Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J Clin Invest. 2006;116:2173-2182.
40. Zaynagetdinov R, Ryzhov S, Goldstein AE, et al. Attenuation of chronic pulmonary inflammation in A2B adenosine receptor knockout mice. Am J Respir Cell Mol Biol. 2010;42:564-571.
41. Zhong H,Wu Y, Belardinelli L, et al. A2B adenosine receptors induce IL- 19 from bronchial epithelial cells, resulting in TNF-alpha increase. Am J Respir Cell Mol Biol. 2006;35:587-592.
42. Khoa ND, Montesinos MC, Reiss AB, et al. Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. J Immunol. 2001;167:4026-4032.
43. Bolli R, Becker L, Gross G, et al. NHLBI working group on the translation of therapies for protecting the heart from ischemia. Myocardial protection at a crossroads: The need for translation into clinical therapy [review]. Circ Res. 2004;95:125-134.
44. Cohen MV, Yang X, Downey JM. A(2b) adenosine receptors can change their spots. Br J Pharmacol. 2010;159:1595-1597.